Flaherty Keith T.

CIK 00015793104 companiesBOULDER, CO

SEC Profile

Transactions

Companies

Filings

CIK

0001579310

Recent Transactions

50 trades

Disposition to Issuer
Kinnate Biopharma Inc.
Stock Option (right to buy)
2024-04-03−20,250→ 0 total
Disposition to Issuer
Kinnate Biopharma Inc.
Common Stock
2024-04-03−66,377→ 0 total
Disposition to Issuer
Kinnate Biopharma Inc.
Stock Option (right to buy)
2024-04-03−32,064→ 0 total
Disposition to Issuer
Kinnate Biopharma Inc.
Stock Option (right to buy)
2024-04-03−20,250→ 0 total
Disposition to Issuer
Kinnate Biopharma Inc.
Stock Option (right to buy)
2024-04-03−56,112→ 0 total
Disposition to Issuer
Kinnate Biopharma Inc.
Stock Option (right to buy)
2024-04-03−11,391→ 0 total
Disposition to Issuer
Kinnate Biopharma Inc.
Stock Option (right to buy)
2024-04-03−25,000→ 0 total
Award
Kinnate Biopharma Inc.
Stock Option (right to buy)
2023-06-12+25,000→ 25,000 total
Award
Kinnate Biopharma Inc.
Stock Option (right to buy)
2022-06-13+20,250→ 20,250 total
Disposition to Issuer
Checkmate Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2022-05-31−4,012→ 0 total
Disposition to Issuer
Checkmate Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2022-05-31−10,030→ 0 total
Disposition to Issuer
Checkmate Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2022-05-31−22,736→ 0 total
Award
Checkmate Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2021-06-16+10,030→ 10,030 total
Award
Kinnate Biopharma Inc.
Stock Option (right to buy)
2021-06-11+20,250→ 20,250 total
Award
Clovis Oncology, Inc.
Stock Option (right to buy)
2021-06-10+42,223→ 42,223 total
Award
Clovis Oncology, Inc.
Stock Option (right to buy)
2020-06-04+40,138→ 40,138 total
Award
Clovis Oncology, Inc.
Stock Option (right to buy)
2019-06-06+28,882→ 28,882 total
Disposition to Issuer
Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
2019-02-15$235.00/sh−15,625→ 0 total
Disposition to Issuer
Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
2019-02-15$235.00/sh−7,812→ 0 total
Disposition to Issuer
Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
2019-02-15$235.00/sh−7,812→ 0 total
Disposition to Issuer
Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
2019-02-15$235.00/sh−68,620→ 0 total
Disposition to Issuer
Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
2019-02-15$235.00/sh−2,500→ 0 total
Disposition to Issuer
Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
2019-02-15$235.00/sh−8,750→ 0 total
Disposition to Issuer
Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
2019-02-15$235.00/sh−32,345→ 0 total
Disposition to Issuer
Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
2019-02-15$235.00/sh−31,459→ 0 total
Disposition to Issuer
Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
2019-02-15$235.00/sh−12,500→ 0 total
Disposition to Issuer
Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
2019-02-15$235.00/sh−11,000→ 0 total
Disposition to Issuer
Loxo Oncology, Inc.
Common Stock
2019-02-15$235.00/sh−9,732→ 0 total
Award
Clovis Oncology, Inc.
Stock Option (right to buy)
2018-10-11+14,770→ 14,770 total
Award
Loxo Oncology, Inc.
Director Stock Option (right to buy)
2018-06-13+8,750→ 8,750 total
Sale
Loxo Oncology, Inc.
Common Stock
2018-06-07$175.10/sh−4,743→ 15,154 total
Exercise/Conversion
Loxo Oncology, Inc.
Director Stock Option (right to buy)
2018-06-07−50,000→ 32,345 total
Sale
Loxo Oncology, Inc.
Common Stock
2018-06-07$171.15/sh−5,021→ 52,811 total
Sale
Loxo Oncology, Inc.
Common Stock
2018-06-07$174.04/sh−16,037→ 19,897 total
Exercise/Conversion
Loxo Oncology, Inc.
Common Stock
2018-06-07$1.18/sh+50,000→ 59,732 total
Sale
Loxo Oncology, Inc.
Common Stock
2018-06-07$173.32/sh−12,243→ 35,934 total
Sale
Loxo Oncology, Inc.
Common Stock
2018-06-07$175.97/sh−5,422→ 9,732 total
Sale
Loxo Oncology, Inc.
Common Stock
2018-06-07$169.85/sh−1,900→ 57,832 total
Sale
Loxo Oncology, Inc.
Common Stock
2018-06-07$172.03/sh−4,634→ 48,177 total
Award
Loxo Oncology, Inc.
Director Stock Option (right to buy)
2018-01-04+2,500→ 2,500 total
Sale
Loxo Oncology, Inc.
Common Stock
2017-11-20$75.35/sh−4,489→ 12,493 total
Sale
Loxo Oncology, Inc.
Common Stock
2017-11-20$77.33/sh−1,961→ 9,732 total
Sale
Loxo Oncology, Inc.
Common Stock
2017-11-20$76.29/sh−800→ 11,693 total
Sale
Loxo Oncology, Inc.
Common Stock
2017-08-21$72.65/sh−3,450→ 16,982 total
Sale
Loxo Oncology, Inc.
Common Stock
2017-08-21$71.91/sh−3,800→ 20,432 total
Award
Loxo Oncology, Inc.
Director Stock Option (right to buy)
2017-06-22+11,000→ 11,000 total
Award
Clovis Oncology, Inc.
Stock Option (right to buy)
2017-06-08+10,000→ 10,000 total
Sale
Loxo Oncology, Inc.
Common Stock
2017-05-22$44.64/sh−4,341→ 27,141 total
Sale
Loxo Oncology, Inc.
Common Stock
2017-05-22$45.75/sh−2,799→ 24,342 total
Sale
Loxo Oncology, Inc.
Common Stock
2017-05-22$46.24/sh−110→ 24,232 total

Companies

Recent Filings

Address

C/O CLOVIS ONCOLOGY, INC. 2525 28TH STREET, SUITE 100

BOULDER, CO, 80301

View on SEC.gov